Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Veterinary medicines
Particular products
Specially reglemented substances
GMO
Public consultation

Medicines
- Medicines
Particular products
Health products
- Distribution

Public consultation

Under construction.

Last updated on 01/01/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

22/07/2019

Update on the new Clinical Trial Regulation pilot project

18/07/2019

Flash VIG news: reassessment of risk of meningioma on cyproterone

18/07/2019

PRAC July 2019 – EMA recommends new measures to avoid dosing errors with methotrexate and has started a review of meningioma risk with cyproterone medicines

11/07/2019

Valproate: knowledge of the risks associated with taking during pregnancy - Results of the 2018 FAMHP survey

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact